SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cirtran Corp. – ‘10-Q/A’ for 6/30/20

On:  Thursday, 8/20/20, at 3:40pm ET   ·   For:  6/30/20   ·   Accession #:  1493152-20-16406   ·   File #:  0-49654

Previous ‘10-Q’:  ‘10-Q’ on 8/19/20 for 6/30/20   ·   Next:  ‘10-Q’ on 11/23/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/20/20  Cirtran Corp.                     10-Q/A      6/30/20   61:2.4M                                   M2 Compliance LLC/FA

Amendment to Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q/A      Amendment to Quarterly Report                       HTML     32K 
 2: EX-31.01    Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-32.01    Certification -- §906 - SOA'02                      HTML     18K 
10: R1          Document and Entity Information                     HTML     48K 
11: R2          Consolidated Balance Sheets                         HTML    117K 
12: R3          Consolidated Balance Sheets (Parenthetical)         HTML     26K 
13: R4          Consolidated Statements of Operations (Unaudited)   HTML     79K 
14: R5          Consolidated Statements of Stockholders' Deficit    HTML     43K 
15: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    103K 
16: R7          Basis of Presentation                               HTML     21K 
17: R8          Summary of Significant Accounting Policies          HTML     47K 
18: R9          Going Concern and Realization of Assets             HTML     22K 
19: R10         Property and Equipment                              HTML     26K 
20: R11         Related-Party Transactions                          HTML     25K 
21: R12         Other Accrued Liabilities                           HTML     28K 
22: R13         Commitments and Contingencies                       HTML     26K 
23: R14         Notes Payable                                       HTML     22K 
24: R15         Convertible Debentures                              HTML     27K 
25: R16         Derivative Liabilities                              HTML     23K 
26: R17         Stockholders' Deficit                               HTML     20K 
27: R18         Stock Options and Warrants                          HTML     22K 
28: R19         Discontinued Operations                             HTML     36K 
29: R20         Subsequent Events                                   HTML     21K 
30: R21         Summary of Significant Accounting Policies          HTML     86K 
                (Policies)                                                       
31: R22         Summary of Significant Accounting Policies          HTML     32K 
                (Tables)                                                         
32: R23         Property and Equipment (Tables)                     HTML     25K 
33: R24         Other Accrued Liabilities (Tables)                  HTML     28K 
34: R25         Notes Payable (Tables)                              HTML     22K 
35: R26         Convertible Debentures (Tables)                     HTML     26K 
36: R27         Derivative Liabilities (Tables)                     HTML     21K 
37: R28         Discontinued Operations (Tables)                    HTML     38K 
38: R29         Summary of Significant Accounting Policies          HTML     41K 
                (Details Narrative)                                              
39: R30         Summary of Significant Accounting Policies -        HTML     23K 
                Schedule of Inventory (Details)                                  
40: R31         Summary of Significant Accounting Policies -        HTML     24K 
                Schedule of Financial Assets and Liabilities                     
                Carried at Fair Valued Measured on Recurring Basis               
                (Details)                                                        
41: R32         Going Concern and Realization of Assets (Details    HTML     28K 
                Narrative)                                                       
42: R33         Property and Equipment (Details Narrative)          HTML     22K 
43: R34         Property and Equipment - Schedule of Property and   HTML     47K 
                Equipment and Estimated Service Lives (Details)                  
44: R35         Related-Party Transactions (Details Narrative)      HTML     86K 
45: R36         Other Accrued Liabilities (Details Narrative)       HTML     21K 
46: R37         Other Accrued Liabilities - Schedule of Accrued     HTML     24K 
                Liabilities (Details)                                            
47: R38         Other Accrued Liabilities - Schedule of Accrued     HTML     30K 
                Payroll and Compensation Liabilities (Details)                   
48: R39         Commitments and Contingencies (Details Narrative)   HTML     59K 
49: R40         Notes Payable (Details Narrative)                   HTML     21K 
50: R41         Notes Payable - Schedule of Notes Payable           HTML     25K 
                (Details)                                                        
51: R42         Convertible Debentures (Details Narrative)          HTML     33K 
52: R43         Convertible Debentures - Schedule of Convertible    HTML     40K 
                Debentures (Details)                                             
53: R44         Convertible Debentures - Schedule of Convertible    HTML     30K 
                Debentures (Details) (Parenthetical)                             
54: R45         Derivative Liabilities (Details Narrative)          HTML     32K 
55: R46         Derivative Liabilities - Schedule of Derivative     HTML     30K 
                Liabilities at Fair Value (Details)                              
56: R47         Stockholders' Deficit (Details Narrative)           HTML     31K 
57: R48         Stock Options and Warrants (Details Narrative)      HTML     48K 
58: R49         Discontinued Operations - Schedule of Discontinued  HTML     68K 
                Operations (Details)                                             
60: XML         IDEA XML File -- Filing Summary                      XML    109K 
59: EXCEL       IDEA Workbook of Financial Reports                  XLSX     67K 
 4: EX-101.INS  XBRL Instance -- cirt-20200630                       XML    708K 
 6: EX-101.CAL  XBRL Calculations -- cirt-20200630_cal               XML    179K 
 7: EX-101.DEF  XBRL Definitions -- cirt-20200630_def                XML    288K 
 8: EX-101.LAB  XBRL Labels -- cirt-20200630_lab                     XML    789K 
 9: EX-101.PRE  XBRL Presentations -- cirt-20200630_pre              XML    521K 
 5: EX-101.SCH  XBRL Schema -- cirt-20200630                         XSD    152K 
61: ZIP         XBRL Zipped Folder -- 0001493152-20-016406-xbrl      Zip     88K 


‘10-Q/A’   —   Amendment to Quarterly Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the quarterly period ended June 30, 2020
   
[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the transition period from ______________ to _______________

 

Commission File No. 000-49654

 

CirTran Corporation

(Exact name of registrant as specified in its charter)

 

Nevada   68-0121636
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)

 

6360 S Pecos Road, Suite 8, Las Vegas, NV 89120

(Address of principal executive offices and zip code)

 

(801) 963-5112

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer [  ] Accelerated filer [  ]
  Non-accelerated filer [X] Smaller reporting company [X]
  Emerging growth company [  ]  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of August 14, 2020, there were 4,500,417 shares of common stock, $0.001 par value, outstanding.

 

 

 

 C: 
 
 

 

EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 to the Quarterly Report on Form 10-Q/A for the quarterly period ended June 30, 2020 of CIRTRAN CORPORATION (the “Company”) filed with the Securities and Exchange Commission on August 19, 2020 (the “Form 10-Q”) isto furnish Exhibits 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.

 

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

 

 C: 
 
 

 

PART II—OTHER INFORMATION

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as a part of this report:

 

Exhibit

Number*

  Title of Document   Location
         
Item 31   Rule 13a-14(a)/15d-14(a) Certifications    
31.01   Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14   This filing.
         
Item 32   Section 1350 Certifications    
32.01   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.

 

* All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.

 

 C: 
 
 

 

SIGNATURE PAGE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CIRTRAN CORPORATION
   
Dated: August 20, 2020 By: /s/ Iehab Hawatmeh
    Iehab Hawatmeh, President
    Principal Executive and Financial Officer

 

 C: 
 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q/A’ Filing    Date    Other Filings
Filed on:8/20/20
8/19/2010-Q
8/14/20NT 10-Q
For Period end:6/30/2010-Q,  NT 10-Q
 List all Filings 
Top
Filing Submission 0001493152-20-016406   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:24:59.1pm ET